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Abstract 1 
 2 
Purpose: To review the published scientific literature concerning clinical and material 3 
degradations of intraocular lenses (IOL) after implantation in cataract surgery. 4 
 5 
Methods: A search was undertaken using the following databases: CENTRAL (including 6 
Cochrane Eyes and Vision Trials Register; The Cochrane Library: Issue 2 of 12, February 7 
2019), Ovid Medline(R) without Revisions (1996 to February Week 2 2019), Ovid Medline(R) 8 
(1946 to February Week 2 2019), Ovid Medline(R) Daily Update Feb 19, 2019, Medline and 9 
Medline Non-Indexed Items, Embase (1980 to 2019 week 07), Embase (1974 to 2019 10 
February 19), Ovid Medline(R) and Epub Ahead of Print, in-Process & Other Non-Indexed 11 
Citations and Daily (1946 to February 19, 2019), Web of Science (all years), the metaRegister 12 
of Controlled Trials (mRCT) (www.controlled‐trials.com), ClinicalTrials.gov 13 
(www.clinicaltrial.gov) and the WHO International Clinical Trials Registry Platform (ICTRP) 14 
(www.who.int/ictrp/search/en). Only published articles in English were selected. Search 15 
terms/keywords included ‘IOL’ or ‘intraocular lens’, combined with: ‘opacification’, 16 
degradation, glistenings, nanoglistenings, whitening, transmittance, light scatter, 17 
discolouration/discoloration, performance, quality, material, biocompatibility, calcification, 18 
explantation, ultraviolet/UV radiation. Relevant in-article references not returned in our 19 
searches were also considered. 20 
 21 
Results: 22 
After review of the available articles, the authors included 126 publications in this review, 23 
based on the quality of their methodology and their originality. The studies included in this 24 
review were randomized controlled trials, cohort studies, case-controlled studies, case 25 
series, case reports, laboratory studies and review papers. Differing material degradations 26 
of IOLs have been described and their associated pathophysiology studied. Reported 27 
anomalies include photo-chemical alterations, water vacuoles, internal and surface calcific 28 
deposits, surface coatings and discolouration. The nature of such changes has been shown 29 
to depend on the type of IOL material used and/or manufacturing processes and storage 30 
conditions employed.  Changes in the IOL can also be influenced by surgical technique, co-31 
existing ocular pathologies and topical and systemic medications. The clinical significance of 32 
these degradations is variable, with some resulting in significant visual disturbance and the 33 
need for IOL explantation and others producing only minimal visual impairments. Failure to 34 
recognise the precise nature of the problem may lead to unnecessary laser capsulotomy 35 
procedures.  36 
 37 
Conclusions: Clinical degradations of IOLs are uncommon but have been reported following 38 
the implantation of IOLs made of differing biomaterials. Their correct identification and 39 
thorough investigation to determine the underlying cause is necessary for optimal patient 40 
management and the prevention of such problems. Choosing a lens made of a particular 41 
material may be important in patients with certain ocular conditions.  42 
 43 
 44 
 45 
 46 
 47 
 3 
Introduction 1 
 2 
Cataract surgery is the commonest surgical intervention in the developed world, with more 3 
than a million such surgeries being conducted per annum in the US, 350,000 in the UK and 4 
20 million world-wide 1. With modern surgical techniques, visual and refractive outcomes 5 
are excellent with almost 95% of eyes achieving 0.3LogMar corrected acuity or better. 2 As 6 
such, not only is it the most common surgical intervention but also one of the most 7 
successful, with increasingly high outcome expectations 3. 8 
 9 
Amongst the many innovations that have contributed to the superior outcomes of modern 10 
cataract surgery, the development of the intraocular lens (IOL) implant is of paramount 11 
importance. The concept of replacing the cataractous lens in cataract surgery with a 12 
prosthetic implant to improve unaided visual acuity and reduce dependence on spectacles, 13 
was first proposed by Sir Harold Ridley who implanted the IOL on the 8th February 1950 at 14 
our unit, St. Thomas’ Hospital, in London 4. These initial lenses were manufactured by 15 
Rayner Ltd (Worthing, UK) and made of Perspex CQ polymethylmethacrylate (PMMA). This 16 
material was apparently chosen as Sir Harold had noted that it was inert after seeing Royal 17 
Air Force personnel with pieces of intraocular Perspex from shattered canopies in World 18 
War II 4. 19 
 20 
Any IOL, implanted during cataract surgery needs to meet certain basic criteria such as being 21 
biocompatible, causing no inflammation or tissue reaction either in the short (months), 22 
medium (years) or long-term (decades), have excellent optical properties to restore vision 23 
and maintain its clarity and shape. Whilst clinical and material degradations of IOLs are 24 
uncommon, they have been reported and may cause significant visual impairment, 25 
necessitating lens explantation. Several types of degradations including photo-chemical 26 
material alterations, surface precipitations, depositions with the IOL material itself, water 27 
vacuolation (glistenings), surface coatings and discolouration have been described. 28 
Investigation of these changes show them to be typically related to the type of IOL material 29 
used and/or the manufacturing process to create such implants. Such conditions need to be 30 
recognized not only to avoid unnecessary laser capsulotomies, which may make any 31 
subsequent lens explantation problematic, but also to limit the future occurrence of such 32 
problems. The purpose of this review is to describe the clinically apparent material 33 
degradations that can occur in IOLs, how and why they have occurred and their typical 34 
clinical consequences and management.  35 
 36 
 37 
Degradation/opacification/discolourations within the IOL 38 
 39 
Photochemical material degradations of PMMA IOLs 40 
The first IOLs were manufactured from PMMA. 4 This material appeared to be 41 
biocompatible and has been successfully used in cataract surgery for almost seven decades. 42 
Indeed, whilst in modern small-incision cataract surgery, rigid PMMA IOLs have been 43 
superseded by foldable silicone and acrylic polymers, they are still implanted as sulcus 44 
lenses and often routinely in the developing world, where phacoemulsification small-45 
incision surgery may not be available.  46 
 4 
 1 
In 2002 Apple et al.5 reported 25 cases in 18 patients of late-postoperative degeneration 2 
(typically over 10 years) of three-piece posterior chamber PMMA IOLs of which 10 were 3 
explanted due to visual loss. They documented spherical, white-brown crystalline 4 
opacifications within the optic of the IOL, composed of compressed, degenerated PMMA 5 
surrounded by an outer clearer area, which they described as “snowflake-like”. This 6 
condition occurred in lenses from more than one manufacturer but in some cases was 7 
restricted to certain lot numbers. Since this time other investigators have documented 8 
similar cases 6-11. They also typically occurred several years after implantation, are present in 9 
the central and mid-peripheral zones of the optic with a clear zone around the optic edge, 10 
which is the portion covered by iris. The anomalies are usually focal with intervening areas 11 
of clarity, but occasionally can coalesce to form a confluent area of opacification. These 12 
opacities are not on the surface but within the anterior third of the substance of the optic 13 
and on X-ray spectroscopy the lesions are made of non-organic material5-7. They do not 14 
disappear when the lens is explanted and dried, which distinguishes them from glistenings 15 
(described later), which are typically small water filled vacuoles. However, while these 16 
snow-flake lesions are described as “dry”, water does collect within the affected area upon 17 
hydration, presumably from associated surface cracks and this can worsen the opacification 18 
7. 19 
 20 
Based on the findings described above, it has been postulated that the changes may be due 21 
to chronic light exposure causing material degradation of the PMMA. The exact nature of 22 
this material photo-chemical degradation is unknown and requires further investigation, but 23 
Werner et al.6 have suggested that possible causes might have been insufficient post-24 
annealing of the cured PMMA polymer, excessive thermal energy during  curing causing 25 
voids in the polymer matrix, non-homogeneous distribution of  the  ultraviolet  26 
chromospheres  and/or possible poor filtration of pre-cured   monomeric   components. It is 27 
unlikely that this degeneration will represent a significant problem in the future, as the 28 
majority of these lenses were implanted in the 1980s to early 1990s, so the majority of 29 
patients are now deceased. In addition, manufacturing processes have changed over the 30 
past three decades and modern PMMA lenses are mostly produced by lathing, which 31 
eliminates the possible causative steps postulated above. 32 
 33 
 34 
Glistenings 35 
 36 
Glistenings are small water-filled vacuoles within the IOL material (Figure 1).  They are 37 
reported to be between 1 and 30 micrometers (m) in size and are thought to occur when 38 
water permeates micro-channels within the IOL material and forms small inclusions 12-14. 39 
Due to the difference between the refractive index of the glistenings and the IOL material, 40 
they act as refractile particles that glisten on slit lamp examination. The first reports of 41 
glistenings date to 1984 and were described by Dr. Norman Ballin in a ‘Surgidev Leiske’ IOL 42 
with a hydrophobic poly (methyl methacrylate) optic 15. He later acknowledged credit for 43 
the actual initial observations of glistenings to Dr John Pearce, who had observed them 44 
several years earlier (J. Pearce, MD, "Glistenings Observed in Injection-moulded Optics" 45 
[letter], Ocular Surgery News, October 15, 1985) 15.  46 
 47 
 5 
Whilst most reports of glistenings have been in hydrophobic acrylic lens materials 16-19, they 1 
have also been reported in PMMA 17, 20 silicone 17, 21 and hydrophilic acrylic IOLs 22. Tognetto 2 
et al. 16, while investigating glistenings prospectively in a series of foldable IOLs, found them 3 
to be present in silicone (CeeOn Edge 911A, Pharmacia & Upjohn, NJ, Bridgewater, USA and 4 
SI-40NB; Allergan, Irvine, CA, USA), hydrophilic acrylic (ACR6D, Corneal®, Corneal 5 
Laboratories, Pringy, France, Hydroview H60M, Bausch and Lomb Surgical, Rochester, NY, 6 
USA and Stabibag, IOLTECH laboratories, Carl Zeiss Meditec Inc, Germany), and hydrophobic 7 
acrylic (AcrySof, Alcon Laboratories, Fort Worth, TX, USA and Sensar ,AMO, Santa Ana, CA, 8 
USA) IOLs. However, the hydrophobic acrylic ‘AcrySof’ group had a higher percentage and a 9 
greater density of glistenings than the other IOLs studied 16. Similarly, Rønbeck, followed 10 
patients implanted with three different IOL materials for 12-years and found glistenings in 11 
all three IOLs but they were more prevalent in the hydrophilic acrylic lenses (AcrySof 12 
MA60BM), than in the silicone (SI-40NB, AMO) or heparin-surface-modified PMMA IOLs 13 
(8090C, Pharmacia & Upjohn) 17.  14 
 15 
The incidence of glistenings varies between published studies. In AcrySof IOLs, Davison 23 16 
reported an 11% incidence of glistenings in the AcrySof SA30AL and 0% in the AcrySof 17 
SA60AT model (Alcon Laboratories Inc, Fort Worth, TX, USA) albeit at only 3 months, while 18 
Waite and Faulkner 24 reported a 100% incidence in AcrySof SA60AT and SN60AT models 19 
and Leydolt et al.25 a 97% incidence in AcrySof SN60WF IOLs at 3 years. Kahraman et al.26 20 
found that the presence of glistenings increased from 66% at 1 year to 86% at 3 years and 21 
was 100% at 5 years post-implantation of the AcrySof SA60AT IOL. This was similar to 22 
Tognetto et al.16 who documented an increase in the incidence of glistenings in AcrySof IOLs 23 
with time, while interestingly they seemed to stabilize after 6 months in IOLs composed of 24 
other materials. 25 
 26 
This increase in glistening with time in AcrySof IOLs has been reported in several studies 27-27 
31. Dhaliwal et al. 27 identified that in a series of AcrySof IOLs, glistenings developed within 28 
weeks after implantation, but in some patients the number of glistenings reduced with time. 29 
Christiansen et al. 13 found no statistically significant increase in glistenings over a four-year 30 
follow-up period, although there was a positive trend. Colin et al.28 in a retrospective study 31 
of AcrySof SN60AT, SN60WF, SA60AT IOLs found stabilisation of glistenings over time, with 32 
over 2 years follow up in many eyes. More recently, Johansson 29, found that glistenings 33 
developed in AcrySof SN60WF IOLs, with an increase between 2 and 3 years after 34 
implantation, with as part of this randomized, controlled study, only a small number of 35 
glistenings seen in hydrophobic acrylic ZCB00 IOLs (AMO, Santa Ana, CA, USA) with no 36 
increase in their number in these lenses with follow-up. Similarly, Moreno-Montanes 30 37 
reported that frequency and intensity of glistenings in AcrySof MA30BA IOLs increased with 38 
time up to 30 months after surgery and Behndig et al. 31, with Scheimpflug photography, 39 
documented an increase in glistenings number with time with a mean follow-up time of 40 
105+/-33months (range 21 to 137 months). 41 
 42 
Two main theories concerning the development of glistenings in IOLs have been proposed32, 43 
namely: water absorption due to environmental temperature change12; and osmolarity 44 
change under isothermal conditions 33. The first theory is based on the observation that the 45 
water absorption rate of polymers changes according to temperature. This theory proposes 46 
that glistenings are a result of IOL material water absorption due to environmental 47 
 6 
temperature changes 12. The second theory proposes that a change in the osmolarity of the 1 
external environment within the eye can lead to an influx of water into the IOL material 2 
under isothermal conditions33. It is of note that the IOL material water content varies in 3 
differing materials. Hydrophobic acrylic polymers generally have a low water content (less 4 
than 0.5%)34, as do silicone IOL materials (less than 0.4%)34,35 and PMMA IOLs (0.4-0.8%)34, 5 
while hydrophilic acrylic materials have higher water contents (up to 38% in some 6 
materials)34. However, the water content can vary in different environmental and aqueous 7 
solutions and how this may or may not relate to glistenings formation is unknown. 8 
 9 
AcrySof is composed of a cross-linked polymer network that can absorb significant amounts 10 
of water, which can be increased with temperature changes. Dhaliwal et al.27, showed that 11 
glistenings were related to hydration of the acrylic material and that they could be reversed 12 
by drying the IOL for 48 hours. Kato et al.12reported that even small changes in temperature 13 
(e.g. 37°C to 34°C) were enough to initiate glistenings formation and proposed that this 14 
occurrence may involve spinodal decomposition of the swollen polymer network, initiating 15 
the formation of microvacuoles consisting of water and loosely packed network chains. Kato 16 
et al.12 showed that water content of the IOL material increases upon heating and that 17 
glistenings formation occurs upon their cooling, and the latter is also dependent on the rate 18 
of temperature change.  19 
 20 
Whilst, changes in temperature 12, 27, equilibrium water content36, osmotic changes33, 21 
environmental factors 36, 37 and equilibrium water content 14 are important in the 22 
development of glistenings in IOLs, other factors are also relevant. Control of the 23 
polymerisation process, to make it as uniform as possible, appears to play a role 32, with 24 
surface scattering and glistenings formation found to be more significant with IOLs 25 
manufactured by cast moulding than by lathe cutting 32. In order to reduce the occurrence 26 
of glistenings in AcrySof IOLs, Alcon Inc. altered the manufacturing process in the early 27 
2010s, implementing tight environmental and process controls in the formulation, cast 28 
moulding and curing operations 38-39. Subsequently, Miyata et al. found that surface light 29 
scattering due sub-surface nano-glistenings was significantly reduced 38 and Thomes and 30 
Callaghan found that the percentage of IOLs with glistenings, induced in the laboratory, with 31 
a density of >100 per mm2 was 99% in the 2003 AcrySof IOL models and only 4.8% in 32 
AcrySof IOLs manufactured in 2012. 39 33 
 34 
Breakdown of the blood aqueous barrier (BAB) and intraocular inflammatory factors may 35 
also be associated with the development of glistenings. Dick et al.40 found that with AcrySof 36 
IOLs the incubation of these lenses in fluid containing serum increased vacuolation. They 37 
proposed that lipids within the serum can reach the cavitations in the acrylic material and 38 
become visible, as the space between the cross-linked molecule chains in the AcrySof 39 
polymer enhances the deposition of such hydrophobic substances. It is of note that an 40 
association between glistenings and diabetes mellitus, where there is often a breakdown of 41 
the BAB, has been documented 32, 40. Werner et al., reported an incidence of glistenings in a 42 
group of diabetic patients of 76% compared to 47% in non-diabetic patients 32. Indeed, they 43 
found that 21% of their so called higher-grade glistenings were in those patients with 44 
diabetes compared with 5.5% in non-diabetics 32. Interestingly, Colin at al. 28 documented an 45 
association between the incidence of glistenings and glaucoma, which it has been 46 
postulated may be due to preservatives in topical anti-glaucoma medicines that can lead to 47 
 7 
the breakdown of the BAB. In addition, uveitis 41 and post-operative inflammation 37, which 1 
both result in BAB breakdown, have been linked with glistenings formation. Indeed, 2 
complex/prolonged surgery, which typically results in a higher degree of inflammation and 3 
BAB breakdown, has been found to be associated to glistenings occurrence 37.  4 
 5 
Other suggested factors that might be associated with the development of glistenings 6 
include the ‘tightness’ of the capsular bag 42 and the presence and degree of anterior 7 
capsular opacification (ACO)29.  This was postulated, as in a few randomized, controlled 8 
studies the ZCB00 IOL (AMO, Santa Ana, CA, USA), which is made of a hydrophobic acrylic 9 
polymer, appeared to have much less propensity to glistenings development than similar 10 
Alcon AcrySof IOLs, also manufactured from an acrylic polymer. As the ZCB00 IOL has an 11 
elevated anterior rim, which lifts the anterior capsule from the anterior optic surface, 12 
appearing to result in less anterior capsular fibrosis than that seen with the AcrySof lenses 13 
that are biconvex, it was then suggested that the occurrence of ACO and capsular bag 14 
‘tightness’ might be important in glistenings creation 26, 29. 15 
 16 
Finally, a positive correlation between higher IOL power and the presence of glistenings has 17 
been established 37, 43, although this relationship appears intuitive as higher-powered IOL 18 
are thicker with a larger volume of material, and therefore may have a greater chance of 19 
developing degradations.  20 
 21 
Clinical studies investigating the association between glistenings and visual performance 22 
have produced conflicting results. Whilst most have demonstrated no significant effect of 23 
glistenings on vision 24, 28, 43-47 a few have found that high numbers of such vacuoles within 24 
IOLs impair visual performance 13, 48, especially high spatial frequency contrast sensitivity 27, 25 
49, 50, 51. Waite et al. 24 in a longitudinal study of up to 3 years in AcrySof IOLs, found no 26 
correlation with corrected distance visual acuity (CDVA) and glare testing and glistening size 27 
or density, although they felt that the effects of glistenings on high spatial resolution 28 
contrast acuity required further investigation. Mönestam et al., 43 in a series of 103 patients 29 
with 10-year follow-up, documented no significant impact between glistenings grade and 30 
vision, including low contrast visual acuity at 10% and 2.5%. Colin et al. 28 in a series of 157 31 
of 260 eyes with glistenings and up to 7 years follow-up in some eyes, found no association 32 
between glistenings and visual acuity. The same research group in a further study of yellow-33 
tinted AcrySof IOL in 111 eyes of 74 patients 44, reported that although there was a trend 34 
toward decreased visual acuities at higher glistening grades, there were no significant 35 
differences in CDVA between their glistening severity groups. Chang et al. 45 in 80 patients in 36 
a randomized, controlled trial at 5-7 years after surgery stated that glistenings were not 37 
correlated with CDVA and confirmed this in a follow up study of the patients at 9 years 46.  38 
 39 
However, Christiansen et al. 13 in 42 eyes implanted with AcrySof IOLs found that Snellen 40 
acuity in eyes with severe glistenings grades was statistically less than those with mild 41 
glistenings. Xi et al.49 in 120 eyes implanted with AcrySof IOLs at 2 years following surgery 42 
found that while there was no statistical correlation between glistening grades and unaided 43 
distance visual acuity (UDVA), CDVA and contrast sensitivity, sub-analysis did show more 44 
eyes with severe glistening grades had reduced contrast sensitivity at high spatial frequency. 45 
Henriksen et al. 48, in 79 eyes with glistenings in AcrySof IOLs showed a correlation between 46 
glistening size and density and distance acuity and contrast acuity with glare. Gunenc et al. 47 
 8 
50 in 34 eyes with glistenings in a series of 94 eyes found no statistically significant difference 1 
in visual acuity and contrast sensitivity at low or medium spatial frequencies between eyes 2 
with glistenings and those without, although they did document a difference at high spatial 3 
frequency. Schweitzer et al. 51 in 67 pseudophakic eyes in 47 patients with co-existing 4 
glaucoma not only showed that a higher number of topical glaucoma medication were 5 
associated with a higher glistening severity grade (probably due to breakdown of the BAB as 6 
discussed above), but that higher grades of glistenings density had lower mean contrast 7 
sensitivity values at high spatial frequencies, although there was no difference in CDVA.  8 
 9 
It seems therefore that in most eyes glistenings are likely to have little effect on visual 10 
performance, except in some eyes with very high densities of glistenings, when high spatial 11 
contrast acuity is preferentially affected. It is of note, however, that most of these studies 12 
have used subjective glistening grading systems with the methods for using these scales 13 
often unclear 13, 14, 27, 44,47, 50. Whilst the number of glistenings is likely to be important, size 14 
and distribution might also be expected to affect vision. Most reported glistenings grading 15 
systems have a 3-4-point ordinal scale, which might lack sensitivity depending on the grade 16 
boundaries and implementation.  In addition, and importantly, published studies typically 17 
rely on subjective counting and grading of glistenings ‘per field’ of slit lamp 13,52 or ‘in the slit 18 
lamp’ 28, 44 without defining the regions of the IOL being studied or the illumination 19 
parameters used when viewing the glistenings. Clearly, such lack of standardization will 20 
introduce variability in glistenings assessment that could provide a partial explanation for 21 
the differences in the results of studies described above using subjective assessment.  In 22 
addition, a further important variable will be differences in the visual tests employed in 23 
these studies and their sensitivities and the existence in some eyes of visually significant co-24 
morbidities. To address such issues, in a recent study the authors47 using a defined, 25 
reproducible, standardized 8-point ordinal scale of glistenings density and an array of 26 
computerized visual function tests, including contrast sensitivity and forward scatter, 27 
investigated the visual effects of glistenings in vivo in 34 eyes implanted with AcrySof IOLs 28 
(SA60AT; Alcon Laboratories Inc., Fort Worth, TX, USA) in patients with no other ocular or 29 
neurological morbidities. They found no association between glistening grades and visual 30 
function47. 31 
 32 
Additional evidence that supports the results of studies that demonstrate glistenings have 33 
little effect on vision comes from explantation rates. In 2013, 67 cases of IOL glistenings 34 
associated with visual impairment were reported to Canadian government, one of which 35 
was said to have been explanted 53. Similarly, Raven et al. 54 reported a case where an 36 
AcrySof IOL required explantation due to intractable symptoms in bright light and when 37 
driving at night. Dogru et al. 55 also reported such a case, although it is of note that this 38 
patient developed glistenings several months after neodymium:YAG laser capsulotomy and 39 
this may have contributed to development of glistenings by disrupting the IOL material 40 
integrity. Similarly, Werner et al. 56 reported a case of explanted 3-piece AcrySof IOL 41 
because of glistenings that impaired fundus visualisation. Because of co-existent retinal 42 
disease, the effects of glistenings on visual function could not in this case be ascertained. It 43 
appears therefore that glistenings can, albeit very rarely, cause clinically significant changes 44 
in vision. Hopefully, however, with the improvement in AcrySof IOL manufacture, 45 
introduced in the early 2010s and the development of newer ‘glistenings free’ hydrophobic 46 
acrylic polymers such problems may be negated. 47 
 9 
 1 
Post-operative degradation/opacification of silicone IOLs 2 
 3 
Werner et al. 57 reported on 6 cases of 3-piece Silicone IOLs (SI-40NB, Allergan, Westport, 4 
Ireland) which required explantation due to early (hours after surgery) opacification and 5 
associated visual loss. The lenses had been implanted in 4 different locations in Brazil and 6 
France, with the Brazilian lenses stored at the same location. The lenses underwent 7 
microscopy (including electron microscopy in one case) as well as gas chromatography/mass 8 
spectrometry (GC/MS) analysis and/or extraction by isopropyl alcohol or acetonitrile. All 9 
lenses had white optic opacification in the hydrated state, becoming transparent on drying. 10 
Unusual exogenous chemical compounds were identified, including terpenes and ketones, 11 
which are typically found in industrial cleaning agents and fumigants. It was postulated by 12 
the authors (although no clear history of chemical contamination could be identified) that 13 
spraying of the storage area with cleaning compounds and insecticides caused chemical 14 
contamination of the IOLs rendering the silicone material more hydrophillic so the influx of 15 
water into the IOL material was rapidly possible after implantation 57. It is of note that many 16 
IOLs are enclosed in semipermeable packages to allow sterilization by ethylene oxide gas, 17 
while at the same time being impermeable to infective micro-organisms and contaminants. 18 
It is therefore feasible that during cleaning or disinfection of storage rooms, aerosolized 19 
solutions might introduce chemicals through the package and onto the IOLs.  20 
 21 
Elgohary et al.58 reported two similar cases of silicone (multifocal) IOLs, with opacification 22 
occurring within weeks of surgery. No obvious cause was apparent, and they suggested that 23 
possible causes might be the presence of low molecular weight silicone fractions that were 24 
not cross-linked during the curing process, large polymer impurities due to inadequate 25 
filtering leading to IOL hydration and interaction between silicone and intraoperative or 26 
postoperative medications. Tanaka et al. 59 also reported a similar case of a silicone SI-40NB 27 
(Allergan, Westport, Ireland) IOL which opacified with a brown haze within 24 hours of 28 
implantation, requiring explantation. Microscopic examination of the extracted IOL showed 29 
numerous spheroid structures, which the authors proposed may be due to water 30 
incorporation into the silicone IOL material.   31 
 32 
Milauskas 60 in 1991 reported 15 cases of brownish discolouration of two silicone IOLs, 33 
manufactured by IOLAB Corp, Claremont, CA, USA and STAAR Surgical Co., Monrovia, CA, 34 
USA, which was documented 15 to 60 months after implantation. Visual acuity was 20/30 or 35 
better in all cases and no lenses were explanted. Two similar cases in the same lens type 36 
were reported by Koch and Heit in 1992 61. No cause for this problem was identified, but it 37 
could be postulated that it may be due to ingress of water/water vapour into the lens due to 38 
anomalies in the manufacturing process. It is of note that the effects on visual performance 39 
appeared to be minimal and there have been no further reports in the literature possibly 40 
due to improvements in manufacturing techniques. 41 
 42 
In 2007 Werner et al. 62 reported 12 cases of late (4 weeks to 2 years) opacification of 43 
silicone lenses in the USA. The opacification was generally less than they had observed in 44 
their series of early onset (weeks) opacification of silicone IOLs 57. They undertook GC-MS 45 
analysis as in their previous study and found benzophenone in 7 of the 12 IOLs, which may 46 
 10 
or may not have been implicated. Improvements in the manufacturing process since this 1 
problem was documented seems to have prevented the problem from recurring. 2 
 3 
Jones and Irwin 63 in 2002 reported a case of ‘rose-colour’ discolouration of a silicone IOL 4 
(model SI30NB; Allergan Inc., Irvine, CA, USA). This patient had undergone bilateral cataract 5 
surgery several years earlier. This patient had been on Rifabutin therapy for Mycobacterial 6 
infection for over 10 months, which was discontinued after the IOL discolouration was 7 
documented. Corrected visual acuity was 20/20 and there was no perceived visual acuity or 8 
colour discrimination problems by the patient, so the IOLs were not explanted. In a 9 
laboratory investigation 63, the authors immersed IOLs from 4 different manufacturers 10 
representing 3 materials for 1 week in a concentrated Rifabutin solution. All lenses 11 
remained clear except for the silicone lenses which were discoloured rose, with the 12 
discolouration fully penetrating the lens.  13 
 14 
In 2007 Werner et al. 64 reported discolouration of a silicone IOL (SI40 NB; AMO, Irvine, CA, 15 
USA) in a patient who presented immediately post-operatively with corneal oedema and a 16 
blue IOL. A ‘blue dye’ had been used to enhance visualization during capsulorhexis. It was 17 
determined that methylene blue had been used instead of trypan blue in this case staining 18 
the IOL. The IOL was explanted and the corneal oedema resolved within 1 month. 19 
Microscopic analysis of the explanted IOL revealed that its surface and internal substance 20 
had been permanently stained blue. In a separate experiment, the authors immersed IOLs 21 
of differing materials (silicone, hydrophobic acrylic, hydrophilic acrylic, PMMA) in methylene 22 
blue at varying concentrations. All IOLs, except the PMMA lenses were permanently stained, 23 
with the hydrophilic acrylic lenses stained most intensely 64. Methylene blue is not 24 
appropriate for intraocular usage, with Tryptan blue being the appropriate dye for anterior 25 
capsule staining. 26 
 27 
Katai et al. 65 in 1999 reported a case of ‘brown’ discolouration of silicone IOLs (STAAR 28 
Surgical Co., Monrovia, CA, USA) in both eyes of the same patient. This patient had been 29 
treated with Amiodarone for 3 years. It was proposed that Amiodarone can cross BAB under 30 
certain conditions, and possibly after vitrectomy, which this patient also underwent in their 31 
left eye, and which resulted in unilateral worsening of discolouration. Contrast sensitivity 32 
and blue colour sensitivity were found to be impaired in this patient’s right eye. The authors 33 
proposed that minute particles including water vapour that could not be removed by 34 
filtering may have also caused this brown discolouration. 35 
 36 
Sathyan et al. 66 reported a non-progressive green discolouration in a silicone IOL (Allergan 37 
SI-40NB, USA). This was documented 6 months after surgery in 2 patients. Contrast 38 
sensitivity without glare was slightly reduced but not the visual acuity and the patients were 39 
asymptomatic. No cause for discolouration has been elucidated. In 2008, Venkatesh et al. 67 40 
reported a similar case of green IOL discolouration. There were no visual complaints and the 41 
patient had a best-corrected visual acuity of 20/20 with normal colour vision and contrast 42 
sensitivity. The explantation was required and no cause is yet established. 43 
 44 
 45 
Opacification/discolourations of hydrophilic acrylic IOLs 46 
 47 
 11 
Werner et al. 68 in 2002 reported a blue discolouration of a hydrogel IOL ‘Acqua’ intraocular 1 
lens (IOL) (Mediphacos, Belo Horizonte, MG, Brazil). This patient underwent cataract surgery 2 
using Trypan blue 0.1% to stain anterior capsule and presented at 7 days with ‘dark and 3 
double’ vision, with CDVA of 20/60. After explantation two months later, CDVA improved to 4 
20/25. Microscopic analysis showed dark blue staining, denser in the optic, especially in its 5 
periphery, with the blue discoloration remaining even after 24 hours of immersion in 6 
balanced salt solution. Tryptan blue should probably be avoided in cases where a high-water 7 
content IOL, such as hydrophilic acrylic IOLs, is to be implanted and/or complete anterior 8 
chamber irrigation undertaken before lens implantation. 9 
 10 
Goodal and Ghosh in 2004 69 reported 5 cases with ‘total IOL’ opacification a single-piece 11 
acrylic hydrophilic IOL (AquaSense IOL, Ophthalmic Innovations Inc., Ontario, CA, USA). In 12 
two cases opacification was mistaken for posterior capsule opacification (PCO) and in one 13 
case for a non-resolving diabetic vitreous haemorrhage. The patients in 5 of these cases had 14 
significant visual deterioration due to total opacification of the IOL more than a year after 15 
surgery and explantation was performed in most cases. After consultation with the 16 
manufacturer, it was suspected that opacification was due to an interaction between the 17 
silicone sleeve, used to hold the IOL in the vial, and the acrylic material of the IOL, which 18 
may have created negative charge resulting in opacification. These IOLs have been 19 
withdrawn. 20 
 21 
Opacification/discolourations of hydrophobic acrylic IOLs 22 
 23 
Manuchechri et al.70 described ‘brown deposits’ in IOLs in a series of pseudophakic, uveitis 24 
patients (54 patients; 71 eyes). These were said to be distinct from glistenings and difficult 25 
to image. The implantation of AcrySof MA60BM hydrophobic acrylic IOLs was strongly 26 
associated with these deposits. This lens is known to be associated with glistenings 27 
formation. One can therefore speculate that these deposits might have been a variation of 28 
glistenings. Albeit, rather than water vacuoles, the vacuoles within these IOLs may have 29 
contained different organic/inorganic material in association with the uveitis documented in 30 
these cases and perhaps topical medications used to treat this condition.  31 
 32 
More recently, a series of 14 brown discoloured AAB00, ZCB00 and ZMBOO IOLs (Abbott 33 
Medical Optics, USA) was recently reported by Wong et al. 71. The browning of the IOLs was 34 
noted as early as day 1 post op and as late as 327 days. No patients had loss of lines of 35 
CDVA.  However, desaturated Lanthony D15 Hue test was abnormal in 8 of 16 eyes. The 36 
authors were not able to find a clinical cause for the discolouration but suspected it was due 37 
to impurities in the IOL that occurred during the manufacturing process. No patient required 38 
IOL exchange. 39 
 40 
Twenty years after his first report of brown discolouration in silicone IOLs, Milauskas 72 in 41 
2012, reported brown discolouration of 2 AcrySof (no specific IOL model provided but 42 
author suggested a blue-light filtering IOL) hydrophobic acrylic IOLs and a yellow 43 
hydrophobic acrylic PY-60AD IOL (Hoya Surgical Optics GmbH). The implantation of these 44 
IOLs was between 6 months and 8 years. In some of these IOLs, glistenings co-existed with 45 
discolouration, and the author noted that discolouration occurred around glistenings. He 46 
also concluded that both Alcon and Hoya IOLs used the same blue-filtering agent, and that 47 
 12 
glistenings may play a role in discolouration of IOLs. Assessment of visual function was 1 
difficult due to multiple patient comorbidities.  2 
 3 
Surface depositions/degradations/coatings of IOLs 4 
 5 
Calcification  6 
 7 
The deposition of calcium within tissues, may be either physiological or pathological, and 8 
can also occur on any bio-prosthetic or biomaterial implant in the human body such as heart 9 
valves, blood pumps, intrauterine contraceptive devices, contact lenses, scleral buckles and 10 
IOLs 73. Neuhann et al.73 have proposed three possible routes for IOL calcification: primary 11 
calcification which is related to the IOL itself (e.g. the polymer, manufacturing or packaging 12 
process); secondary, that is not only dependent on the IOL but also associated with pre-13 
existing disease, that may involve breakdown of BAB; and false positive calcification or 14 
pseudo-calcification that occurs due to misdiagnosis of tissue artefacts or incorrect use of 15 
special stains. 16 
 17 
The pathogenesis of IOL calcification is not fully understood 74. Two possible mechanisms 18 
have been proposed for calcification of biomaterials: intrinsic (material-dependent) and 19 
extrinsic (host- and cell-dependent) 73. Extrinsic calcification may be due to foreign body 20 
reaction to the biomaterial and it has been suggested that blood cells, devitalized cells, 21 
bacterial, inflammatory cells or lipids may provide an initial nidus for calcification 73. 22 
 23 
IOL calcification has most commonly been associated with surface deposition on hydrophilic 24 
acrylic IOLs 73-74, but also has been reported in silicone IOLs in the presence of asteroid 25 
hyalosis 75-76. Wackernagel et al. 75 and Foot el al. 76 in the early 2000s reported opacification 26 
of plate haptic IOLs occurring a few years after cataract surgery in the presence of unilateral 27 
asteroid hyalosis. These lenses were explanted, and white deposits were documented on 28 
the posterior lens surface only. Light microscopy, scanning electron microscopy and 29 
dispersive x-ray spectrometry showed the deposits consisted of calcium and phosphate, 30 
presumably hydroxyapatite. It was hypothesized that this deposited material might be 31 
derived from the asteroid bodies within the vitreous themselves or due to the process that 32 
is responsible for this condition. Werner et al. 77 described a similar case in one eye 33 
implanted with a 3-piece silicone IOL SI30 NB (AMO, Irvine, CA, USA) in a patient with 34 
bilateral asteroid hyalosis. The IOL was explanted, while the other eye in which an acrylic 35 
IOL was implanted did not develop opacities with 6 years of follow-up. More recently, 36 
Stringham et al.78 (16 eyes) and Espandar et al. 79 (3 eyes) have also described cases with 37 
posterior surface calcification on silicone IOLs in the presence of asteroid hyalosis. In the last 38 
report laser capsulotomy was documented to make IOL explantation/exchange problematic 39 
77. While such cases are rare considering the vast numbers of silicone IOLs that have been 40 
implanted, the use of such lenses in the presence of pre-existing asteroid hyalosis needs to 41 
be carefully considered and the selection of an IOL with another material may be prudent. 42 
 43 
As discussed above IOL surface calcification has most commonly been on hydrophilic acrylic 44 
IOLs 74-75. Apple et al. 80 and Werner et al.81 in 2000 were the first to describe calcification in 45 
foldable hydrogel ‘Hydroview’ IOLs (Bausch and Lomb Surgical, Rochester, NY, USA). Surface 46 
staining of explanted IOLs with Alizarin red, suggested that the deposits on the lens surface, 47 
 13 
both anterior and posterior, were composed of calcium and phosphates. According to this 1 
group at this time in 2000, there had been 76 cases in 9 centres worldwide with the same 2 
anomaly and in 17 of these cases the IOLs were explanted.  3 
 4 
There have since been multiple reports in several different hydrophilic acrylic IOL models 5 
from different manufacturers both in the USA and Europe 6, 73, 82-86. Within the US during the 6 
early 2000s,  four major designs of IOLs seem to have had problems with deposits on the 7 
optic surface made up largely of calcium and phosphate: ‘Hydroview’ (Bausch & Lomb 8 
Surgical, Rochester, NY, USA), ‘Memory Lens’ (Ciba Vision Duluth, GA, USA), ‘SC60B-OUV’ 9 
(Medical Developmental Research, Clearwater, FL,) and ‘Aqua-Sense’ IOLs (Ophthalmic 10 
Innovations International, Claremont, CA, USA) 6, 73, 82-86. Time to explantation of these IOLs 11 
was approximately 2 years with microscopic analysis, as well as x-ray spectroscopy of 12 
explanted IOLs confirming the presence of calcium and phosphate within the deposits on 13 
the IOL hydrophilic acrylic surfaces 81-86.  14 
 15 
The precise patho-physiology of the factors involved in the calcification of these IOLs is yet 16 
undetermined.  Dorey et al. 84 using energy dispersion x-ray spectrometry showed that 17 
many of the deposits were composed of calcium and phosphate in an electron-dense 18 
periphery with silicone in the electron-lucent centre. They proposed that the silicone gasket 19 
in the ‘Surefold’ packaging system, manufactured specifically for the ‘Hydroview’ IOL, might 20 
be responsible, contaminating the lens with silicone particles on the IOL surface, which then 21 
act as a nidus for calcium deposition 84. It was of note that the IOLs in packaging prior to 22 
introduction of the silicone gasket did not appear to opacify and that the manufacturer 23 
(Bausch and Lomb) changed packaging to one sealed with a gasket made from a 24 
perfluoroelastomer rather than silicone to negate this problem. Guan et al. 87 and Wu et 25 
al.88 examined the role of silicone compounds in the calcification of hydrophilic acrylic IOLs, 26 
examining their interaction with long saturated fatty acids. They showed that IOL surfaces 27 
treated with fatty acids, such as behenic acid, present in aqueous humour, calcify in vitro. 28 
They suggested that hydrophobic cyclic silicones adsorbed on the IOL surfaces can interact 29 
with hydrophobic hydrocarbon chains of the fatty acids to create a layer of amphiphiles 30 
which may act as sites of calcification 87. Werner et al. 86 also demonstrated the presence of 31 
silicone compounds on the ‘Memory Lens’ IOL and on and within SC60B-OUV and Aqua-32 
Sense IOLs, suggesting their importance in the development of calcification of these 33 
hydrophilic acrylic lenses as well. Ophthalmic Innovations International (‘Aqua-Sense’ IOL) 34 
subsequently excluded siloxane silicone elastomers from their IOL packaging components to 35 
address possible contamination problems. In addition to manufacturers removing silicone 36 
compounds from their acrylic hydrophilic IOL packaging, Ciba vision changed its polishing 37 
process of its ‘Memory Lens’ IOL with which it correlated the opacification problem 82. 38 
Hunter et al. 89 reported a single case of calcification in a ‘Memory Lens’ IOL manufactured 39 
after this time, although this was attributed an intrinsic defect in the optic itself and not the 40 
mechanism described above. 41 
 42 
Gartaganis et al. 90 examined explanted opacified hydrophilic acrylic IOLs, from the 4 types 43 
described above, chemically analysed aqueous humour from eyes in which the IOLs had 44 
been explanted and conducted in vitro experiments. They concluded that the opacification 45 
is due to the deposition of calcium phosphate crystallites, with hydroxyapatite 46 
predominating and the surface hydroxyl groups of the polyacrylic material polymer 47 
 14 
facilitating surface nucleation and calcific crystalline growth 90. They also suggested that the 1 
calcium and phosphate may be derived from residual cataractous material and surgical 2 
technique such as cortical clean-up may be of importance, explaining the occurrence of 3 
unilateral cases in patients implanted with the same lens type in both eyes. 4 
 5 
Since these initial case series and studies and despite changes in manufacturing and 6 
packaging, there have been multiple reports of calcification of other hydrophilic acrylic IOLs 7 
in the past decade, both in cataract surgery and other surgical situations. Werner et al. 91 8 
published in 2015 a series of 7 hydrophilic acrylic IOLs, 6 designs from 5 manufacturers that 9 
required explantation due to granular calcific surface deposits within the margins of the 10 
capsulorhexis or the pupil on the anterior IOL surface/sub-surface that caused decreased 11 
visual acuity. These deposits had developed in these eyes after the patients underwent 12 
Descemet’s stripping endothelial keratoplasty (DSEK) (Figure 2). The authors proposed three 13 
possible causes for this calcification including: direct contact between the intra-cameral air 14 
and hydrophilic acrylic IOLs material; intra-cameral metabolic changes because of the 15 
presence of exogenous substances injected during surgery; and exacerbated inflammatory 16 
reaction with breakdown of the BAB due to the surgical procedure itself 91. They suggested 17 
that surgeons should be aware of this phenomenon following DSEK and Descemet’s 18 
stripping automated endothelial keratoplasty (DSAEK) procedures in pseudophakic patients 19 
with hydrophilic acrylic IOLs and counsel patients accordingly 91. Similarly, Giers et al.92, 20 
reported the occurrence of opacification of 13 hydrophilic IOLs, months to years after 21 
DSAEK and Descemet’s membrane endothelial keratoplasty (DMEK), identifying a thin layer 22 
of calcium-phosphate deposition just beneath the central, anterior IOL surface. These lenses 23 
typically required explantation92. Such reports suggest that surgeons might be advised to 24 
avoid using hydrophilic acrylic IOLs in patients who are likely to require corneal endothelial 25 
lamellar surgery, such as in eyes with  (e.g. Fuchs’ endothelial and other corneal endothelial 26 
dystrophies. 27 
 28 
In addition to the injection of air/gas into the anterior chamber during DMEK/DSAEK 29 
procedure, similar changes have been reported after pars plana vitrectomy (PPV) and 30 
intravitreal gas injection. Recently, Marcovich et al.93, reported 11 cases of hydrophilic IOL 31 
opacification, 1 month to 6 years after PPV with gas injection, with calcium and phosphate 32 
deposition on the anterior, central IOL surface in explanted IOLs93. They suggested that a 33 
hydrophobic IOL may be preferred when a simultaneous phacoemulsification and 34 
vitrectomy with intravitreal gas being considered. It is of note, however, that there have 35 
been recent case reports of calcification of hydrophobic acrylic IOLs (AcrySof SA60AT; Alcon 36 
Laboratories Inc., Fort Worth, TX, USA) associated with intravitreal gas injection and 37 
retained perfluorocarbon liquid following vitreoretinal surgery, so that this problem is not 38 
entirely related to hydrophilic Acrylic polymers94. 39 
Aside from air/gas injections, recombinant tissue plasminogen activator (rtPA) has also been 40 
recently reported to cause IOL opacification secondary to calcification in hydrophilic acrylic 41 
IOLs (Rayner C-Flex 570C and Rayner Superflex 620H; Rayner, Worthing, UK). Fung et al.95  in 42 
a case series of 7 eyes of 7 patients reported IOL anterior surface/subsurface opacification, 43 
which stained positive for calcium salts, within 12 months of the use of rtPA to treat 44 
inflammatory membranes that formed after cataract surgery. They proposed that the rtPA 45 
may have released sequestered calcium from the fibrinous inflammatory membranes and 46 
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introduced phosphate ions contained in its buffer solution, potentiating calcium 1 
deposition95.  2 
 3 
Other reports of IOL calcification include those by, Tandogan et al.96 who documented in 4 
2015 a series of explanted opacified ‘Euromaxx ALI313Y’ and ‘ALI313’ IOLs (Argonoptics, 5 
Germany) hydrophilic acrylic IOLs. X-ray spectroscopy revealed fine granular surface 6 
deposits made of calcium and phosphate. These IOLs were explanted due to reduced visual 7 
acuity, the reasons for the calcification in these eyes was not elucidated. Similarly, 8 
Zuberbuhler and Carifi 97 in 2012 reported a series of 5 patients with glittering deposits on 9 
the surface of hydrophilic acrylic IOLs (3 C-flex 970C IOLs, Rayner, Worthing, UK, and 2 with 10 
Akreos AO, Bausch and Lomb Surgical, Rochester, USA). Disposable forceps were found to 11 
be the cause of these during injector loading process. None of the patients experienced 12 
visual symptoms. The IOLs did not undergo staining to see if theses deposits were calcific 97.  13 
 14 
In addition, there have been a number of recent reports concerning calcification in hybrid 15 
hydrophilic acrylic IOLs with hydrophobic surfaces manufactured by Oculentis GmbH, Berlin, 16 
Germany 98-99 (Figures 3a and 3b). Gartaganis et al. 98 reported 6 cases with the Lentis LS-17 
502-1 IOL, 2 of which had undergone vitreo-retinal procedures. Analysis confirmed the 18 
presence of subsurface formation of calcium phosphate crystalline deposits. Gurabardhi et 19 
al. 99 in 2018 reported the largest series so far (71 eyes, 63 patients) of these cacifiied acrylic 20 
hydrophilic IOLs with hydrophobic surfaces (LS-502-1, LS-402-1Y, LS 312-1Y, LS-313-1Y, L-21 
402, L-312). Light microscopy revealed numerous granules within opacified areas (optic 22 
and/or haptic), close to the surface or on the surface of the IOLs, which were positive for 23 
alizarin red 1% suggesting calcium deposition. The lenses were implanted between 2009 and 24 
2012 and explantation was performed 4 years ± 1.2 (SD) after initial phacoemulsification. 25 
Ocular and systemic comorbidities were found without statistical correlation, with the most 26 
frequent being diabetes, uveitis, and glaucoma. A definitive cause was not identified but it 27 
was suggested by the authors that a manufacturing issue might be the reason 99. This has 28 
been supported by a voluntary recall of lenses, implemented by Oculentis first in December 29 
2014 who stated at that time that “analysis suggests a possible interaction between 30 
phosphate crystals originating from the hydration process of the IOL material and the 31 
fluctuating, batch related presence of silicone residues on some IOLs’’. According to relevant 32 
literature, such residues may potentially change the IOL surface properties, making it under 33 
certain medical conditions more prone to deposition of calcium phosphate from the 34 
aqueous humour in predisposed patients. These deposits may compromise the optical 35 
transparency of the IOL, potentially leading to a reduction in the patient’s visual acuity.” In 36 
September 2017 Oculentis issued a further ‘Field Safety Notice’, applying to all Lentis 37 
foldable IOLs with model numbers starting with L-, LU- and LS- and having an expiry date 38 
between January 2017 and May 2020. Within this notice they reported that they have 39 
identified the source of calcific opacification as phosphate-containing cleaning agent used in 40 
their production process, which they apparently changed in June 2015. 41 
 42 
Such cases clearly high-light the need for vigilance on behalf of both surgeons and 43 
manufacturers alike to be aware of such problems, strongly consider analysis of any 44 
explanted IOL in a specialist centre to provide a definitive diagnosis, as well as feedback to 45 
the manufacturer and regulatory medical device agency. This requirement for increased 46 
 16 
post-market surveillance of medical devices is stated in the latest Medical Devices 1 
Regulation, issued by the European Union in April 2017A. 2 
 3 
 4 
Sub-surface whitening/nano-glistenings 5 
 6 
Surface light scattering was first reported in hydrophobic acrylic IOLs by Nishihara el al. in 7 
2003 100. They described ‘surface whitening’ of 40 patients implanted with AcrySof 8 
Hydrophobic acrylic IOLs (Alcon Laboratories Inc., Fort Worth, TX, USA). They could only 9 
examine 5 eyes in 4 patients in vivo with a slit lamp and could therefore not elucidate the 10 
cause, as the lenses in these eyes were not explanted. They felt the problem was on the 11 
surface/sub-surface and was not due to glistenings (discussed above) as these are normally 12 
within the substance of the IOL, not on its surface. The authors postulated that the structure 13 
of the IOL polymer might have changed over time with reorganization of the surface or near 14 
the surface to produce such changes. 15 
 16 
Further reports of such phenomena in AcrySof IOLs have attempted to elucidate the nature 17 
of these problems 101-102. Matsushima et al. 101 examined 4 explanted IOLs (due to 18 
dislocation) and found that light transmission in the visible range was only 4% less than that 19 
of unused IOLs, that x-ray analysis showed no calcium phosphate deposits, Fourier-20 
transform infrared spectrophotometry showed no evidence of hydrolysis and that the 21 
opacification disappeared after drying of the IOLs but reappeared with immersion in 22 
physiologic saline. They postulated that it was likely that the ‘whitening’ of the hydrophobic 23 
acrylic IOLs was due to trace water molecules infiltrating sub-surface of the lens optic and 24 
that within the 3-dimensional network of the acrylic lens polymer, water molecules were 25 
able to form aggregates of sufficient size to scatter visible light, causing opacification or so 26 
called  ‘whitening’101 (Figure 4). 27 
 28 
Ong et al.103 described a similar phenomenon to ‘whitening’, in AcrySof IOLs following 29 
explantations in 5 eyes and from human cadavers in 8 eyes, with non-implanted IOLs as 30 
controls. They found no inorganic/organic deposits on the IOL surfaces, but the hydration 31 
state of the IOLs significantly contributed to the intensity of surface light scattering and that 32 
clinically explanted and cadaver-eye explanted IOLs (but not control IOLs) exhibited minimal 33 
scatter when dry, intermediate scatter when wetted, and maximum scatter when hydrated.  34 
They documented on scanning electron microscopy sub-surface ‘nano-glistenings’, with 35 
diameters of less than one micrometre (between 140 and 185 nanometres) and within 36 
120μm of the IOL surface, as the source of the hydration-related surface light scattering. 37 
 38 
Miyata et al.104 investigated this IOL surface light scattering phenomenon and found it was 39 
greater in ‘AcrySof MA60BM’ and ‘AcrySof SA60AT’ IOLs (Alcon Laboratories Inc., Fort 40 
Worth, TX, USA) than that of ‘AR60’ and ‘ClariFlex’ IOLs (AMO, Santa Ana, California, USA), 41 
although of note was that contrast sensitivity under photopic conditions was not statistically 42 
different amongst the four groups of IOLs at any spatial frequency.  They reported that this 43 
scattering was due to uniform, membrane-like whitening of the IOL surface and was distinct 44 
from glistenings, concluding that glistenings and surface scattering differed in both location 45 
and appearance and probably in origin 104. In a follow-up study, Miyata et al. 105 evaluated 46 
the surface light scatter using a Scheimpflug camera in a cross-sectional study of 466 eyes, 47 
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implanted with either AcrySof 3-piece (MA30BA, MA60AC and MA60BM) or 1-piece 1 
(SA60BM) IOLs and showed that surface light scattering continued to increase up to 15 years 2 
post-operatively in all the AcrySof IOLs (Alcon Inc.) 105. Unfortunately, they did not assess 3 
contrast sensitivity or assess for the presence of glistenings in the IOLs in this study, which 4 
could have influenced the results. Takahashi et al.106 performed an optical simulation using 5 
ray-tracing software to evaluate visual effects of subsurface nano-glistenings (SNG) in IOLs. 6 
They found that increased size and volume ratio of SNGs increased forward light scatter but 7 
that the modulation transfer function (MTF) was not affected. They also found that peak 8 
retinal irradiance reduced with increased SNG volume ratios. The limitation of this study 9 
was that the SNGs in this simulation were evenly distributed which is not the case in real life 10 
106. The authors discussed an interesting observation, where visual function improved in 11 
patients with retinal diseases when IOLs with SNGs were replaced. Research has shown 12 
dissociation of Snellen acuity and contrast sensitivity, indicating that contrast sensitivity can 13 
be used as an early index of changes in the retina not demonstrated by measurements of 14 
visual acuity 107. The finding of no effect of SNGs on MTF by Takahashi et al.105 is in line with 15 
findings by Werner et al.108 who investigated light scatter and straylight in 17 AcrySof IOLs 16 
with SNGs removed from cadavers (11 SN60WF and 6 SA60AT; Alcon Inc.). In addition to 17 
MTF, these authors examined Badal images obtained with the explanted IOLs through 18 
different size pupils and found no significant difference to controls (non-implanted IOLs). 19 
There was similar light transmission but increased light scatter in the explanted IOLs 20 
compared to control IOLs. However, the reported values were well below the value of 21 
straylight hindrance and the authors concluded that the light scatter caused by the SNGs 22 
would be unlikely to cause noticeable visual impairments 104. Beheregaray et al.105 also 23 
investigated the impact on visual function of SNGs in 42 eyes implanted with AcrySof IOLs 24 
(models SA60AT, SN60AT, MA60AC, MA60BM) and found that eyes with SNGs had increased 25 
forward light scatter but the CDVA was unaffected compared to 17 eyes implanted with 26 
hydrophobic acrylic iSert 251 or iSert 255 IOLs (Hoya Corp., Shinjuku, Tokyo, Japan) used as 27 
controls. The authors excluded subjects with ocular co-morbidities. They documented that 28 
forward light scatter correlated with reductions in VA and contrast sensitivity, but the values 29 
were within the normal age range.  30 
 31 
It appears therefore that in most eyes, SNGs while increasing light scatter do so at a level 32 
unlikely to be visually symptomatic. However, this is not always the case. In a recent case 33 
report, subjective visual impairment due to SNGs occurred in a single-piece AcrySof IOL 34 
SA60AT (Alcon Inc.) 5 years after IOL implantation with starbursts, flare/glare and cloudy 35 
vision106. Explantation was not performed, as the other eye was amblyopic. It will be of 36 
interest to note if acrylic IOLs manufactured after 2010 will show less propensity to the 37 
development of SNGs and if so-called ‘glistenings-free’ hydrophobic acrylic polymers IOL will 38 
not have this problem. 39 
 40 
 41 
 42 
 43 
 44 
 45 
Coatings of silicone IOLs 46 
 47 
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Silicone Oil 1 
 2 
Late opacification of silicone IOLs due to interaction with silicone oil was reported by Apple 3 
et al.107 in 1996 in 3 eyes. It generally is not seen by the implanting cataract surgeon but 4 
usually later if the patient undergoes vitreo-retinal surgery necessitating the use of silicone 5 
oil. In 2 of the 3 reported eyes the IOLs were explanted, with the silicone oil coating 6 
manifest as a thick droplet-like glaze that was tenaciously adherent to the lens surface and 7 
could not apparently be dislodged by instruments or injection of viscoelastics107. In a further 8 
study, Apple et al.108 performed an in-vitro experimental study to investigate silicone oil 9 
adhesion to various IOLs of different biomaterials, including fluorine-treated, heparin-10 
surface-modified, PMMA, acrylic and silicone IOLs. The oil coverage of dry silicone IOLs was 11 
100% and 82.5% silicone IOLs were immersed in normal saline. The least coverage was on 12 
the heparin-surface-modified lenses (mean score 9.4%). Yaman et al.109 looked at the effects 13 
of heavy silicone oil and found it to be akin to normal silicone oil. The mean heavy silicone 14 
oil coverage was 7.05% +/- 7.88% on PMMA IOLs, 100% on silicone IOLs, 12.17% +/- 11.43% 15 
on hydrophobic acrylic IOLs, and 34.64% +/- 13.28% on hydrophilic acrylic IOLs. Oner et 16 
al.114 also evaluated the interaction between various IOLs, including: hydrophilic acrylic IOLs 17 
(Morcher, type 92s; Morcher GmbH, Germany); hydrophobic acrylic IOLs (AcrySof-SA60AT, 18 
Alcon Inc.); PMMA IOLs (Intraocular Optical International-IOI-65130) and silicone optic IOLs 19 
(CeeOn Edge 911A, Pharmacia UpJohn). Silicone IOLs once again had the highest percentage 20 
(79.9%) coverage whereas hydrophilic acrylic IOLs were the least (7.8%). They found no 21 
effect with varying concentration of the silicone oil. All these studies, show that when 22 
performing small-incision cataract surgery in patients who may be at risk of requiring vitreo-23 
retinal surgery with silicone oil injection e.g. family history of retinal detachment, extreme 24 
myopia, congenital cataract, proliferative diabetic retinopathy, etc., hydrophilic acrylic or 25 
hydrophobic acrylic lenses should be preferred over silicone lenses and that it is best to 26 
avoid, if possible, the use of silicone oil in eyes with pre-existing silicone IOLs. 27 
 28 
Toxic anterior segment syndrome due to ophthalmic ointments and IOL 29 
materials 30 
 31 
Werner et al.111 reported 8 cases of toxic anterior segment syndrome (TASS) related to an 32 
oily substance in the anterior chamber of patients following cataract surgery, with an oily 33 
coating of the IOL in some cases. All cases were performed by the same surgeon using clear 34 
corneal incisions, with implantation of the same type of 3-piece silicone IOL. Immediately 35 
post-operatively antibiotic/steroid ointment and pilocarpine gel was administered and the 36 
eyes firmly patched. On the first day, some patients presented with corneal oedema, raised 37 
intraocular pressure, and an oily film-like material within the anterior chamber coating the 38 
endothelium, while others had an oily bubble floating in the aqueous, which later coated 39 
the IOL. Some of these eyes required additional surgical procedures such as keratoplasty, 40 
IOL explantation, and trabeculectomy. Six explanted IOLs were analysed by microscopy in 4 41 
cases by gas chromatography-mass spectrometry (GC-MS), which confirmed the presence of 42 
an oily substance coating large areas of the anterior and posterior IOL optic surfaces with a 43 
mixed chain hydrocarbon compound seen on GC-MS, akin to that found in the ointment 44 
used post-operatively. Chew at al.112 reported a case, where a patient required lens 45 
repositioning 11 and 13 months after initial apparently uncomplicated surgery and then at 46 
 19 
18 months developed a greasy film over a 3-piece silicone IOL. The lens was explanted, with 1 
GC-MS identifying the presence of hydrocarbons, including docosane, tricosane, and 2 
tetracosane (often found in ophthalmic ointments), on the IOL surface, which matched that 3 
found in one of the ointments used after IOL re-positioning. Chen et al. 113 reported a similar 4 
case, where ‘Garamycin’ (gentamicin; Schering-Plough, USA) ophthalmic ointment, applied 5 
immediately post-operatively, was identified on the surface of an explanted IOL, removed at 6 
3 years due to reduced vision and an oily-like lump on the anterior surface of the IOL. 7 
 8 
It appears from these cases that ophthalmic ointments for topical use only can gain access 9 
to the anterior chamber, and as well as causing damage to other internal ocular structures 10 
can coat the surface of silicone IOLs. Such cases high-light the importance of good wound 11 
construction and post-operative wound integrity and the risks of tight eye patching 12 
following placement of topical ointment. Certainly, there have been several previous 13 
reports of ointment applied externally after reaching the anterior chamber, which has 14 
occurred both after cataract surgery and other anterior segment procedures 113-116, so care 15 
need to be taken with its immediate post-operative usage with any penetrating ocular 16 
surgical wound. 17 
 18 
 19 
Other types of IOL surface degradation: inter-lenticular opacification 20 
 21 
While not a cause of opacification of the IOL itself, inter-lenticular opacification, can result 22 
in significant visual loss necessitating IOL explantation.  Gayton et al. 117 in 2000 presented 23 
two pairs of piggyback AcrySof hydrophobic acrylic IOLs, placed in the capsular bag, which 24 
were explanted because of opacification between the lens optics. There appeared to be a 25 
membrane-like, white material between the lenses, which on histopathological examination 26 
identified retained/proliferative lens epithelial cells mixed with lens cortical material 117. 27 
Werner et al.118 further examined the nature of the inter-lenticular material and 28 
documented that Elschnig pearls, which could be surgically aspirated, were observed in the 29 
peripheral interface between the lenses but the central interface between the lenses was 30 
occupied by an amorphous material, which could not be removed and was acellular on 31 
histological examination. In a follow-up paper, Werner et al.118 reported on the 32 
histopathologic and ultrastructural features of three cases of inter-lenticular opacification 33 
and found the material opacifying the inter-lenticular space was composed mostly of 34 
retained/regenerative cortical material. They concluded that the pathogenesis was akin to 35 
that of posterior capsule opacification and that very careful removal of lens epithelial cells 36 
and cortical material is necessary in cases where piggyback implantation is being considered 37 
119. Such findings were confirmed by Eleftheriadis et al.120 who published 2 pairs of in-the-38 
capsular-bag piggyback AcrySof IOL implantation with bilateral intra-lenticular opacification 39 
in one patient. They documented a central contact zone between the two IOLs, surrounded 40 
by a homogenous paracentral opacity, which in turn were surrounded by Elschnig pearls. 41 
 42 
Werner et al. 121 in an in vivo rabbit study, compared dual-optic silicone IOLs to piggyback in-43 
the-bag IOL implantation with silicone and with hydrophobic acrylic IOLs. They confirmed 44 
that intra-lenticular opacification was significantly associated with pairs of hydrophobic 45 
acrylic lenses implanted in the bag and not silicone IOLs. Finally, Jackson and Koch122 46 
documented a case where in an eye with piggyback implantation, whilst the posterior IOL 47 
 20 
was placed completely within the capsule, one of the haptics of the anterior IOL was 1 
inadvertently placed in the ciliary sulcus and the other in the capsule. They noted that inter-2 
lenticular opacification was localized to the area adjacent to the anterior lens haptic placed 3 
within the capsule but absent from the area near the anterior lens haptic in the ciliary 4 
sulcus. The concluded that sulcus placement of the anterior IOL may help to prevent inter-5 
lenticular opacification. 6 
 7 
Whilst rare, it appears that intra-lenticular opacification is related to paired in-the-capsular-8 
bag hydrophobic acrylic IOLs 117-122. It has been proposed that if such acrylic lenses are being 9 
inserted in the fashion, then meticulous removal of the lens epithelial cells and cortical 10 
material is mandatory. However, silicone lenses seem less susceptible to this complication 11 
and insertion of the anterior IOL into the ciliary sulcus (with an appropriate sulcus lens to 12 
avoid iris trauma and pigment dispersion) and not the capsule, together with correct 13 
placement of the posterior IOL into the capsular bag with complete coverage of the optic 14 
edge by the capsulorhexis, should negate this problem. 15 
 16 
Conclusions 17 
 18 
Over the past decades several differing degenerations, opacifications and discolourations of 19 
IOLs implanted after cataract surgery have been described. Reported anomalies have 20 
included photo-chemical degenerations, water vacuolation, internal and surface calcific 21 
deposits, surface coatings and discoloration. Investigations of the patho-physiology of these 22 
changes depend on the type of IOL material used and/or manufacturing processes and IOL 23 
storage conditions employed and can also be influenced by surgical technique, co-existing 24 
ocular pathologies and topical and systemic medications. The clinical significance of these 25 
degradations is variable, with some resulting in significant visual disturbance and the need 26 
for IOL explantation and others in only minimal optical impairments. Failure to recognise the 27 
precise nature of the problem may lead to unnecessary laser capsulotomy procedures. The 28 
correct identification and thorough investigation to determine the underlying cause is 29 
mandatory both for optimal patient management and the prevention of such problems. 30 
Indeed, there is a paucity of published research investigating the effects of material 31 
degradations of IOL, especially with time, on their optical properties, which needs to be 32 
addressed. 33 
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Figure 1: Slit-lamp photograph of glistenings within an AcrySof IOL appearing as multiple 26 
small refractile bodies within the bulk of intraocular lens optic. 27 
 28 
Figure 2. A hydrophilic acrylic IOL opacified following DSEK (courtesy of Mr. M Nanavaty, 29 
Sussex Eye Hospital, Brighton, UK) 30 
 31 
Figure 3. (a) Slit lamp image of a calcified Lentis (Oculentis, GmbH, Berlin, Germany) 32 
intraocular lens  (Courtesy of Mr. M Rajan, Addenbrookes Hospital, Cambridge, UK); (b) 33 
Electron microscopy (x5000 magnification) of a cross-section of a calcified LentisM30 34 
(Oculentis, GmbH, Berlin, Germany) intraocular lens showing calcium deposits extending 20 35 
μm from the lens surface (Courtesy of Mr J. Stevens, Moorfields Eye Hospital, London, UK) 36 
 37 
Figure 4. Subsurface whitening or nanoglistenings seen as intense light scattering or 38 
whitening on anterior and posterior IOL surfaces. In addition, glistenings can be seen in the 39 
bulk of the IOL optic of an AcrySof SA60AT; Alcon, inc, USA.  40 
 41 
